Volume 60, Issue 5, Pages (November 2011)

Slides:

Advertisements

Similar presentations

Volume 61, Issue 5, Pages (May 2012)

Advertisements

The PSA Era is not Over for Prostate Cancer

Volume 50, Issue 1, Pages (July 2006)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 4, Issue 5, Pages (September 2017)

Volume 47, Issue 4, Pages (April 2005)

Testosterone Therapy in Men With Prostate Cancer

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 69, Issue 5, Pages (May 2016)

Volume 70, Issue 1, Pages (July 2016)

Volume 72, Issue 5, Pages (November 2017)

Volume 74, Issue 2, Pages (August 2018)

Volume 53, Issue 5, Pages (May 2008)

Volume 66, Issue 3, Pages (September 2014)

Volume 73, Issue 6, Pages (June 2018)

Volume 66, Issue 6, Pages (December 2014)

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Prostate Cancer Epidemic in Sight?

Volume 52, Issue 4, Pages (October 2007)

Volume 72, Issue 5, Pages (November 2017)

Volume 63, Issue 4, Pages e53-e56 (April 2013)

Volume 61, Issue 1, Pages (January 2012)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 68, Issue 4, Pages (October 2015)

Volume 54, Issue 4, Pages (October 2008)

What is New in Hormone Therapy for Prostate Cancer in 2007?

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 53, Issue 4, Pages (April 2008)

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 68, Issue 3, Pages (September 2015)

Volume 67, Issue 3, Pages (March 2015)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 71, Issue 5, Pages (May 2017)

Volume 70, Issue 5, Pages (November 2016)

Counselling the Prostate Cancer Patient

Volume 64, Issue 6, Pages (December 2013)

Volume 73, Issue 2, Pages (February 2018)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 5, Pages (May 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Richard C. Harkaway European Urology Supplements

Volume 68, Issue 6, Pages (December 2015)

Volume 72, Issue 6, Pages (December 2017)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 74, Issue 6, Pages (December 2018)

Volume 74, Issue 5, Pages (November 2018)

Testicular Cancer Variations in Time and Space in Europe

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Volume 72, Issue 5, Pages (November 2017)

European Urology is “Your” Journal

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Axel Heidenreich European Urology Supplements

Improving Flexibility and Quality of Life for Your Patients: A Must?

Volume 68, Issue 5, Pages (November 2015)

Volume 53, Issue 6, Pages (June 2008)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Axel Heidenreich European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 60, Issue 5, Pages 881-893 (November 2011) Permanent Interstitial Low-Dose-Rate Brachytherapy for Patients with Localised Prostate Cancer: A Systematic Review of Randomised and Nonrandomised Controlled Clinical Trials Frank Peinemann, Ulrich Grouven, Carmen Bartel, Stefan Sauerland, Holger Borchers, Michael Pinkawa, Axel Heidenreich, Stefan Lange European Urology Volume 60, Issue 5, Pages 881-893 (November 2011) DOI: 10.1016/j.eururo.2011.06.044 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Literature retrieval and study selection. WHO ICTRP=World Health Organization International Clinical Trials Registry Platform; ISRCTN=International Standard Randomised Controlled Trial Number Register; NIHR UKCRN=National Institute for Health Research UK Clinical Research Network's Portfolio Database; NCI PDQ=National Cancer Institute Physician Data Query Clinical Trials; LDR-BT=low–dose rate brachytherapy; RP=radical prostatectomy; EBRT=external-beam radiation therapy; NPT=no primary therapy; PRO=patient-reported outcome; RCT=randomised controlled trial. European Urology 2011 60, 881-893DOI: (10.1016/j.eururo.2011.06.044) Copyright © 2011 European Association of Urology Terms and Conditions